← EU Feed

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

AI Briefing

  • ROSEN law firm investigates Inovio Pharmaceuticals securities class action
  • Investors with losses in INO between Oct 10, 2023 and Dec 26, 2025, urged to act
  • April 7, 2026 lead plaintiff deadline approaches
Advertisement
Read Original Article